Transforming the Pharma Industry with Digital Health Apps (DiGA)

DataArt 19 June 2023, Online.
DataArt, a global software engineering firm, is thrilled to announce its upcoming online panel discussion titled "DiGA for Pharma as Business Growth Opportunity." The event will unite professionals from the pharmaceutical, technology, and regulatory sectors to explore the transformative power of digital health apps. This discussion aims to delve into key topics, including:
  • Understanding why the pharmaceutical industry should be highly interested in DiGA
  • Exploring the inherent suitability of DiGAs for the pharmaceutical sector
  • What is essential for Pharma companies to successfully manage their first DiGA project
  • Addressing regulatory challenges and considerations in adopting DiGAs
  • Identifying the ideal DiGA case for the pharmaceutical sector

This event will feature an exceptional lineup of speakers. Joining us will be Dr. Marcus Rudolf Goetz, Head of Research and Development at Dr. Pfleger Arzneimittel; Olga Romanova, Engagement Manager at DataArt; Oliver Hilgers, Head of Digital Health at NEXTEC Medical; and Dr. Patrik Scholler, a Business Strategy Consultant specializing in Life Sciences.

Through this panel discussion, attendees will gain valuable insights into the advantages that DiGAs offer to the pharmaceutical industry. The session will highlight how DiGAs are uniquely well-suited for the pharma sector, including their potential to enhance patient engagement, improve medication adherence, and enable personalized healthcare experiences. Additionally, the discussion will identify the ideal DiGA case for the pharmaceutical sector, providing attendees with a clear understanding of the potential applications and benefits.

To register and further information, please follow the link:
https://lnkd.in/eP4xMabA

About DataArt

DataArt is a global software engineering firm that takes a uniquely human approach to solving problems. With over 25 years of experience, teams of highly trained engineers around the world, deep industry sector knowledge and ongoing technology research, the company helps clients create custom software that improves their operations and opens new markets.

Most Popular Now

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...

AXREM and Highland Marketing Partner to …

AXREM represents member companies that collectively provide UK hospitals with most of their diagnostic medical imaging technology, and radiotherapy equipment. The association has seen substantial growth in recent years, with membership...